PGBD4P3: A Drug Target / Disease Biomarker (G100421136)

Target Name: PGBD4P3

NCBI ID: G100421136

PGBD4P3

Other Name(s): piggyBac transposable element derived 4 pseudogene 3 | PiggyBac transposable element derived 4 pseudogene 3

PGBD4P3: A Drug Target / Disease Biomarker

PGBD4P3 is a protein that is expressed in various tissues throughout the body. It is a key regulator of the glycolytic pathway, which is a critical pathway for cellular energy metabolism. PGBD4P3 plays a crucial role in the regulation of glucose metabolism by ensuring that glucose is properly produced, processed, and transported to the cells that need it.

One of the unique aspects of PGBD4P3 is its role in the regulation of insulin sensitivity. Insulin sensitivity is the ability of cells to respond to insulin, a hormone that helps regulate blood sugar levels. PGBD4P3 helps to ensure that cells are able to respond properly to insulin, which is essential for maintaining proper glucose metabolism.

In addition to its role in insulin sensitivity, PGBD4P3 is also known for its role in the regulation of inflammation. Inflammation is a natural response of the immune system, but when it becomes chronic or excessive, it can lead to a range of health problems. PGBD4P3 has been shown to have a positive impact on the regulation of inflammation, which can help to reduce the risk of chronic diseases.

Furthermore, PGBD4P3 is also associated with the regulation of cellular processes that are important for the development and maintenance of tissues. For example, it has been shown to play a role in the regulation of cell division and the development of tissues.

As a potential drug target, PGBD4P3 is an attractive target for researchers because of its unique role in the regulation of glucose metabolism, insulin sensitivity, and inflammation. By developing compounds that can modulate PGBD4P3 activity, researchers may be able to develop new treatments for a range of diseases.

Protein Name: PiggyBac Transposable Element Derived 4 Pseudogene 3

The "PGBD4P3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PGBD4P3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets